Table 4.
The mean, median, and SD values of total count of CD45+, CD4+, CD8+, and PD-1+ lymphocytes and the ratio of PD-1+ lymphocytes in CD8+ lymphocytes (PD-1+/CD8+ ratio) for patients in this study, in ADCTA group, and reference group.
| (A) Median count and SD of CD45+, CD4+, CD8+, and PD-1+ lymphocytes and the medial ratio of PD-1+ lymphocytes to CD8+ lymphocytes (PD-1+/CD8+ ratio) in tumor-infiltrating lymphocytes | ||||
|---|---|---|---|---|
| TIL | ADCTA (n = 27) | Reference (n = 20) | ||
| Median | SD | Median | SD | |
| CD45+ | 1,782 | 1,318 | 704 | 1,321 |
| CD4+ | 262 | 326.68 | 130 | 172 |
| CD8+ | 241 | 395.95 | 141.5 | 224.1 |
| PD-1+ | 26 | 213.74 | 40.5 | 196.82 |
| PD-1+/CD8+ | 0.21 | 0.22 | 0.25 | 0.54 |
| (B) Median count and SD of CD4+, CD8+, and PD-1+ lymphocytes and the medial ratio of PD-1+ lymphocytes to CD8+ lymphocytes (PD-1+/CD8+ ratio) in PBMCs | ||||
| PBMC | ADCTA (n = 18) | |||
| Median | SD | |||
| CD45+ | 5,184 | 3,278 | ||
| CD4+ | 2,966.25 | 1,431.55 | ||
| CD8+ | 2,980.00 | 1,442.72 | ||
| PD-1+ | 632.50 | 368.00 | ||
| PD-1+/CD8+ | 0.198 | 0.1773 | ||
TIL, tumor-infiltrating lymphocytes; PBMC, peripheral blood mononuclear cells; PD1, programed death 1.